US2020354736A1PendingUtilityA1

Modified plants and methods for reducing cell wall methylation and recalcitrance

Assignee: UNIV CALIFORNIAPriority: Jul 17, 2017Filed: Jan 17, 2020Published: Nov 12, 2020
Est. expiryJul 17, 2037(~11 yrs left)· nominal 20-yr term from priority
C12Y 303/01002C12N 15/8255C12N 15/8243C12N 5/04C12N 15/8223C12N 9/14C13K 1/02
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides for a genetically modified plant or plant cell comprising a nucleic acid encoding a S-adenosylmethionine hydrolase (AdoMetase) operatively linked to a tissue-specific secondary wall promoter such that there is a specific increased expression of AdoMetase in a secondary cell wall synthesizing tissue when compared secondary cell wall promoter expression compared to corresponding unmodified plant cells.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A genetically modified plant or plant cell comprising a nucleic acid encoding an S-adenosylmethionine hydrolase (AdoMetase) operatively linked to a tissue-specific secondary wall promoter such that there is a specific increased expression of AdoMetase in a secondary cell wall synthesizing tissue when compared secondary cell wall promoter expression compared to corresponding unmodified plant cells. 
     
     
         2 . The genetically modified plant or plant cell of  claim 1 , wherein when grown or cultured there is an increase in H-units and/or β-O-4 linkages formed by the genetically modified plant or plant cell compared to corresponding unmodified plant cells. 
     
     
         3 . The genetically modified plant or plant cell of  claim 1 , wherein the AdoMetase comprises the amino acid sequence of SEQ ID NO:1. 
     
     
         4 . The genetically modified plant or plant cell of  claim 1 , wherein the tissue-specific secondary wall promoter is an IRX1, IRX3, IRX5, IRX8, IRX9, IRX14, IRX7, IRX10, GAUT13, GAUT14, or CESA4 promoter. 
     
     
         5 . A method of producing cell wall modified with an increased amount of H-units and/or and β-O-4 linkages, comprising: (a) providing a genetically modified plant of  claim 1 , (b) growing or culturing the genetically modified plant under conditions in which the AdoMetase is expressed in a secondary cell wall synthesizing tissue, (c) optionally pretreating a biomass formed by the genetically modified plant to form a pretreated biomass, and (d) saccharifying the pretreated biomass to produce one or more sugars. 
     
     
         6 . The method of  claim 5 , wherein the saccharifying step at least about 5% more sugars when compared to the saccharification of biomass grown or cultured from corresponding unmodified plants or plant cells. 
     
     
         7 . The method of  claim 5 , wherein the cell wall of the genetically modified plants or plant cells have at least about 50% more H-units when compared to the cell wall of biomass grown or cultured from corresponding unmodified plants or plant cells. 
     
     
         8 . The method of  claim 5 , wherein the cell wall of the genetically modified plants or plant cells have an about 2.5 to 2.8-fold increase of H-units when compared to the cell wall of biomass grown or cultured from corresponding unmodified plants or plant cells. 
     
     
         9 . The method of  claim 5 , wherein the cell wall of the genetically modified plants or plant cells have at least about 5% fewer S-units when compared to the cell wall of biomass grown or cultured from corresponding unmodified plants or plant cells. 
     
     
         10 . The method of  claim 5 , wherein the cell wall of the genetically modified plants or plant cells have an about 1.4-fold decrease of S-units when compared to the cell wall of biomass grown or cultured from corresponding unmodified plants or plant cells.

Join the waitlist — get patent alerts

Track US2020354736A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.